Cargando…
Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs
BACKGROUND: Persistent antiphospholipid antibodies (aPL) constitute the serological hallmark of the antiphospholipid syndrome (APS). Recently, various new assay technologies for the detection of aPL better suited to multiplex reaction environments than ELISAs emerged. We evaluated the diagnostic per...
Autores principales: | Thaler, Markus A., Bietenbeck, Andreas, Steigerwald, Udo, Büttner, Thomas, Schierack, Peter, Lindhoff-Last, Edelgard, Roggenbuck, Dirk, Luppa, Peter B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655644/ https://www.ncbi.nlm.nih.gov/pubmed/31339913 http://dx.doi.org/10.1371/journal.pone.0220033 |
Ejemplares similares
-
Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome
por: Volkov, Ilan, et al.
Publicado: (2020) -
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
por: Roggenbuck, Dirk, et al.
Publicado: (2016) -
The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination
por: Ott, Olivia, et al.
Publicado: (2023) -
Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
por: Schulz, Annabel, et al.
Publicado: (2022) -
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases
por: Nalli, Cecilia, et al.
Publicado: (2018)